Shire (SHPG), Takeda Shareholders Approve $62 Billion Merger
Takeda Acquisition Of Shire May Bode Well For R&D Staff
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WO
Takeda to cut 'moderately innovative' R&D after $62B Shire buy: Reuters | Fierce Biotech
Shire and Takeda said to be near preliminary merger deal - BNN Bloomberg
Pharma giant Takeda enters into $7.5bn loan agreement to fund Shire takeover
After profits dip Takeda may find solace in Shire merger, says GlobalData - European Pharmaceutical Manufacturer
Reviewing The Takeda-Shire Merger (NASDAQ:SHPG) | Seeking Alpha
SHP647 may take a back seat to Entyvio after Takeda-Shire merger
Japan's Takeda family brands Shire deal 'a disaster' | Business | The Sunday Times
Shire and Takeda come to terms with a $64B deal, the biggest pharma M&A in years | Fierce Pharma
Shire and Takeda to announce preliminary deal after breakthrough in merger talks: Reuters, citing sources
A timeline of the Takeda/Shire merger l Pharma Intelligence
Japan drug giant Takeda tumbles as Shire recommends $64 bn offer
News Release
Takeda takes biggest gamble of 2018 with Shire merger -
Shire, AbbVie unveil $54 billion merger
Takeda and Shire finally agree takeover terms after months of negotiations – The New Economy
Summary
Takeda to sell nearly new Shire plant with 200 employees | Fierce Pharma
Takeda Accelerates Transformation: Solid FY2019 Results, Confidence in FY2020 Growth Momentum | Business Wire
Shire agrees $32bn takeover of Baxalta | Financial Times
Takeda finally snags Shire in $62 billion deal
Takeda Pharmaceutical and Shire receive shareholders' approval for Takeda- Shire deal | AlphaStreet
